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Background: Lymphatic filariasis caused by Wuchereria bancrofti or Brugia spp. is a public health problem in
developing countries. To monitor bancroftian filariasis infections, Circulating Filarial Antigen (CFA) test is commonly
used, but for brugian infections only microfilariae (Mf) microscopy and indirect IgG4 antibody analyses are available.
Improved diagnostics for detecting latent infections are required.
Methods: An optimized real-time PCR targeting the brugian HhaI repeat was validated with plasma from microfilariae
negative Mongolian gerbils (jirds) infected with B. malayi. Plasma samples from microfilaremic patients infected with
B. malayi or W. bancrofti were used as positive and negative controls, respectively. PCR results of plasma samples from
a transmigrant population in a B. malayi endemic area were compared to those of life-long residents in the same
endemic area; and to IgG4 serology results from the same population. To discriminate between active infections and
larval exposure a threshold was determined by correlation and Receiver-Operating Characteristics (ROC) curve analyses.
Results: The PCR detected HhaI in pre-patent (56 dpi) B. malayi infected jirds and B. malayi Mf-positive patients from
Central Sulawesi, Indonesia. HhaI was also detected in 9/9 elephantiasis patients. In South Sulawesi 87.4% of the
transmigrants and life-long residents (94% Mf-negative) were HhaI PCR positive. Based on ROC-curve analysis a
threshold for active infections was set to >53 HhaI copies/μl (AUC: 0.854).
Conclusions: The results demonstrate that the HhaI PCR detects brugian infections with greater sensitivity than
the IgG4 test, most notably in Mf-negative patients (i.e. pre-patent or latent infections).
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Lymphatic filariasis (LF) affects approximately 120 million
people in 73 endemic countries [1]. Wuchereria bancrofti
accounts for ~90% of LF cases, while Brugia malayi and
B. timori infections account for the remainder [2]. Ap-
proximately 15 million people with LF live in Southeast
Asia [3]. Indonesia is part of the Global Programme to
Eliminate Lymphatic Filariasis (GPELF), a multi-national
initiative that aims to eliminate disease transmission by
2020. GPELF employs mass drug administration (MDA)
to reduce filarial infection rates below those required for* Correspondence: pfarr@microbiology-bonn.de
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inating LF caused by B. malayi and W. bancrofti [4,5].
GPELF relies on diagnostic tests to map LF-endemic areas
and to monitor the impact of MDA. Thick blood smear
examination is used for routine diagnosis and prevalence
studies in Brugia endemic countries [6,7]. This method
detects microfilariae (Mf) in the peripheral blood but, due
to the nocturnal periodicity of microfilaremia in these
areas, requires night-time collection, which is unpopular
with the local population. Furthermore, this method is
relatively insensitive [8].
In bancroftian filariasis, circulating filarial antigen (CFA)
can be measured in plasma by a rapid card test [9,10] or
enzyme-linked immunosorbent assay (ELISA). CFA de-
termination revealed that approximately twice as manytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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mic, thus a proportion of Mf-negative people equal to the
Mf-positive people harbors cryptic infections [11]. Visual-
izing adult worms by ultrasonography (USG) is also
possible in W. bancrofti infections which is helpful for
monitoring adult worm viability, e.g. after macrofilari-
cidal treatment [6].
However, for brugian LF, a specific antigen test like
CFA does not exist and USG is unable to detect cryptic
infections [12]. Exposure to brugian parasites is deter-
mined by brugian specific IgG4 serology using recom-
binant antigens in ELISAs [13,14] or rapid-format assays
(BmR1-Brugia Rapid™ [15] and CELISA [16]) with up to
95% sensitivity in Mf-positive samples. The ELISA for-
mat using soluble worm antigen (SWA) was shown to
be more sensitive compared to the rapid-format which
could be due to the mixture of antigens used in the
ELISA. However, IgG4 serology has limited use in cross-
sectional surveys since it does not differentiate latent or
occult infections from exposure to infective larvae. With
less sensitivity it is also cross-reactive with W. bancrofti
related antibodies and therefore has limited use in co-
endemic areas.
Real-time PCR is a powerful tool for high-throughput
detection of parasite DNA and is increasingly replacing
conventional-PCR and microscopy for diagnosis of sev-
eral parasitic infections [17,18]. Using a real-time PCR
assay targeting the B. malayi HhaI repeat, a sensitive
and specific detection of nocturnally periodic B. malayi
DNA in day blood samples was possible including 33%
of Mf-negative samples in a highly endemic area [19].
Recently a multiplex real-time PCR assay for the B.
malayi HhaI and W. bancrofti Long DNA Repeat was
established for use in co-endemic areas [20]. This once
more showed that real-time PCR assays provide a sig-
nificant cost and labor saving procedure for disease
monitoring efforts in endemic locations as part of the
Global Progamme for the Elimination of Lymphatic
Filariasis (GPELF) [20].
We evaluated the usefulness of the B. malayi HhaI PCR
as a diagnostic test, especially focusing on pre-patent, la-
tent (Mf-negative) and occult infections (seen after contin-
ued use of antifilarial drugs, i.e. post-patent), analyzing an
Indonesian transmigrant population, previously analyzed
for B. malayi infection using both IgG4 based tests
[21,22]. Most studies on the dynamics of filarial infec-
tion have been carried out in populations that are life-
long residents of endemic areas. In such situations, the
history of exposure to parasites is hard to determine
and correlate with different diagnostic approaches. This
is only possible when a naive population becomes
exposed to filarial infection abruptly. In Indonesia, a
governmental transmigration program in the 1990’s relo-
cated groups of people from the overcrowded islands ofJava and Bali to under-populated areas on remote islands,
which are often endemic for a multiplicity of infections.
This transmigration policy provided a unique situation
to study the development of infection in individuals
with a known and equal length of exposure to infec-
tions. We present new results concerning the dynamics
of brugian infection in a population with a known time
of residence in an endemic area using a modified qPCR
for B. malayi HhaI that was validated using a novel co-
hort of Mf-negative samples.
Methods
Ethics statement
Human participants: This study used archived material
from a previous project that was reviewed and approved
by the ethics committee of the Medical Faculty Hasanud-
din University, Makassar, South Sulawesi, Indonesia [22].
In co-operation with the medical doctors and health
workers of the local District Health Centre and the head
of each transmigration unit or village, all residents were
informed about the study and invited to participate.
Written informed consent was obtained from all study
participants or parents of children and juveniles before
parasitological studies and blood taking in accordance
with the guidelines of the Indonesian Department of
Health and Human Services.
Plasma from uninfected European controls or Toxo-
plasma spp. and Dirofilaria repens infected patients
was obtained from blood bank volunteers after informed
consent was given. Use of the plasma for diagnosis by
PCR and other methods was approved by the Ethics
Committee of the University Hospital of Bonn.
The use of plasma from Ghanaian volunteers infected
with other parasites (W. bancrofti, Schistosoma spp. and
Strongyloides stercoralis) was approved by the Commit-
tee on Human Research Publication and Ethics at the
University of Science and Technology in Kumasi, Ghana
and by the Ethics Committee of the University Hospital
of Bonn.
Use of animals: All animal protocols were approved by
the University of Edinburgh Ethical Review Committee
(Certificate of Designation PCD 60/2605) and submitted to
the UK Home Office which issued Project Licence PPL60/
3453 for animal studies in the investigator's laboratory. UK
Home Office guidelines to minimize animal suffering were
adhered to at all times.
Participants
Plasma from B. malayi infected patients from Indonesia
were from a larger cross-sectional study between 1990–
1996 conducted in Budong-budong [21,22], a district of
Mamuju Regency in South Sulawesi, Indonesia, endemic
for periodic nocturnal B. malayi [23]. A transmigrant popu-
lation had travelled to their new homesteads in groups
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Lesser Sunda islands as part of the government-sponsored
relocation program. Transmigrants from areas where filar-
iasis is endemic (South Sulawesi and other Lesser Sunda
islands) were excluded from the analysis. A total number of
247 transmigrants and 133 life-long residents (LLR) were
enrolled in the study. For PCR analysis, 334 plasma samples
were available for DNA extraction (Additional file 1).
Detection of B. malayi infection
Venous blood samples (10 ml) were collected between
20:00–24:00 as described [22]. EDTA was added to the
tubes to a final concentration of 0.05 M. After centrifuga-
tion, collected plasma was stored at −20°C until shipment
to Europe and then stored at −70°C until use. Parasito-
logical examination and detection of filarial specific IgG4
antibodies using BmR1 dipstick assay (Brugia Rapid™)
were done in 2004 as previously described [21,22].
DNA extraction and PCR
DNA was extracted from 100 μl plasma with a QIAcube®
(Qiagen, Hilden, Germany) using the QIAamp® DNA Blood
Mini Kit according to the blood and body fluid protocol.
DNA was eluted in 100 μl AE-Buffer.
The PCR assay used a QuantiTect® custom assay with
primers and minor groove binding probe (QuantiProbe®,
Qiagen) to detect 120 bp of the Brugia HhaI repeat
(Additional file 2) [19]. Target sequence copy numbers
were calculated from the Ct values using an external
standard curve generated with an HhaI plasmid dilution
series that had 100% detection in samples with >200
copies/μl and 80% in samples with 20 copies/μl.
Samples containing very low amounts of DNA and
negative for HhaI were measured in a second PCR assay
using the QuantiTect® Virus NR Kit. The modified mas-
ter mix allows the sample DNA to make up 50% of the
PCR reaction and resulted in an improved detection
limit of 2 HhaI copies/μl (Additional file 2). A test for
inhibitors in the DNA samples was done with a refer-
ence plasmid of murine IFN-γ (Additional file 2). An in-
ternal PCR control detected the human β-actin gene
(Additional file 2).
DNA extraction from plasma of B. malayi infected jirds
Male adult jirds (Meriones unguiculatus) were bred and
housed according to Home Office guidelines, United
Kingdom. Jirds with a patent B. malayi infection were
used as a source of venous blood during the pre-patent
infection. Blood was collected by tail bleed from jirds on
day 56 post infection with B. malayi. DNA was extracted
from 100 μl of plasma using the QIAamp® DNA Mini
Kit, eluted in 50 μl and quantified with the QuantiTect®
Virus NR Kit using 2 μl or 10 μl sample DNA per
reaction.DNA extraction from plasma used as negative controls
The specificity of the HhaI PCR assay was tested using
plasma samples collected from volunteers after informed
consent and extracted as above from the following: 10W.
bancrofti patients, 15 patients with other parasitic infections
(Toxocara spp., Schistosoma spp., Strongyloides stercoralis,
Dirofilaria repens or W. bancrofti) and 10 European blood
donors without history of parasitic infection.
Determination of threshold of active infections by real-
time PCR
A threshold limit of HhaI copy numbers was determined
to differentiate most-likely “active” infections (i.e. infections
with live adult worms) from simple exposure to infective
larvae. For this the Mf loads of Mf-positive (Central
Sulawesi and South Sulawesi transmigrants, n = 49) and
LE patients (Central Sulawesi, n = 9) were correlated to
HhaI copies/μl and the Y-intercept was calculated by
linear regression. To verify the results, further analysis was
done by a Receiver Operating Characteristics (ROC) curve
analysis using a binormal mixture model [24,25]. Individ-
ual samples were scored positive with active infection
(Mf-positive, LE n = 58) or negative with possible exposure
to infective or fourth-stage larvae (L3-L4) (n = 50, transmi-
grant samples from the ≤1 month and 2–4 months group,
since L3 to adult development requires ~8 months). The
Area Under the Curve (AUC) for the ROC-curve was cal-
culated to measure the discriminatory power of the PCR
assay [26]. A table of possible thresholds with true- and
false-positive rates (%) was calculated from the coordi-
nates of the ROC curve.
Statistical methods
PASW 18.0 (IBM®, Somers NY, USA) was used to test
the comparison of two binary variables with the Fisher’s
exact test, to correlate two continuous parameters using
Spearman’s rank test and to determine a threshold copy
number by ROC-curve analysis. The ROC-curve proced-
ure is a useful tool to evaluate the performance of classi-
fication schemes that categorize samples into one of two
groups (i.e. HhaI copy numbers of Mf positive (infected)
vs. HhaI copy numbers of Mf negative (exposed but un-
infected)). The further the curve lies above the reference
line, the more accurate the test (AUC). The table with
curve coordinates reports the sensitivity (true positive
rate) and the 1-specificity (false positive rate) for every
possible cutoff. A cutoff of 0 is equivalent to assuming that
everyone is positive, the highest cutoff assumes that every-
one is negative. Both extremes are unlikely, the balance of
sensitivity and 1-specificity is needed to select a cutoff.
The Cochran-Armitage test for trend was calculated
with SAS 9.2 (SAS, Cary, NC, USA) to compare the trend
of HhaI copy numbers between the 1–3 year and the
4–6 year residents.
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To establish a method for detecting cryptic (pre-patent
or latent) B. malayi infections, real-time PCR for HhaI
was used to measure parasite DNA in plasma samples.
Using 2 μl of a HhaI plasmid DNA dilution series and
the Quantitect® Probe master mix, 100% (5/5) of the
samples with 200 copies/μl were detected (Ct 30.5-31).
The reaction detected as few as 2 copies/μl in 50% (5/10)
of the samples (Ct 36.5-37). A detection rate of 80% (4/5)
was achieved for 20 copies/μl and set as the PCR detection
limit (Ct 34.5-35). The reaction efficiency was ≥ 85%
(Additional file 3A). Negative controls did not result in
a signal.
Samples with low DNA concentrations could lead to
false negatives when only using 2 μl of sample DNA. To
increase the sample volume to a maximum of 10 μl, a
second PCR using the QuantiTect® Virus NR Kit was
developed. Using 10 μl of the 2 copies/μl plasmid dilution,
the reaction efficiency was 100% and detected 100% of the
samples (5/5; Ct 33–34; Additional file 3B).
To validate the HhaI PCR assay used for detection of
B. malayi infection in plasma, the real-time QuantiTect®
PCR assay was used on plasma taken eight weeks after
infection from nine infected and nine naive jirds. No Mf
could be found at this time confirming a pre-patent sta-
tus. Patent B. malayi infections in jirds can usually be
detected 75–110 days after infection [27]. All infected
jirds were confirmed to have adult worms (median = 40,
range = 9–76) when the animals were necropsied. The
B. malayi HhaI PCR assay using 10 μl reaction volume
showed a positive signal in all infected jirds 8 weeks post
infection, but was negative in plasma samples from un-
infected jirds (Table 1). Using only 2 μl of template
DNA with the QuantiTect master mix, there was no
detection of the HhaI tandem DNA repeat. The results
confirmed the sensitivity of the HhaI PCR when using
an increased volume of template DNA in pre-patent,
Mf-negative samples.
Plasma samples of European blood donors, 19 samples
with different parasite infections and 10 plasma samples
from W. bancrofti infected patients were tested with the
HhaI PCR 2 and 10 μl assays. These controls were all
negative, confirming the specificity of the HhaI PCR
primers and minor groove binding hybridization probe
as previously reported [19].
The PCR was further validated using samples from
30 Mf-positive individuals from Central Sulawesi and 9Table 1 HhaI detection in plasma from pre-patent jirds (56 da
Animal group HhaI positives
(2 μl sample volume)
Infected jirds (9/9 patent) 0/9
Uninfected jirds 0/9
aMedian (range).elephantiasis patients, one of whom was Mf-positive.
The HhaI gene was detected in all Mf-positive samples
confirming the sensitivity of the PCR in microfilaremic
samples (positive controls). Copy numbers of the HhaI
gene were positively correlated to the number of Mf
(Spearman’s rank correlation, r = 0.48, P = 0.0072). In
the elephantiasis group, the 2 μl PCR assay detected
HhaI in 78% of the samples, although only one patient
was Mf-positive with 1 Mf/ml (Table 2). In the 10 μl
assay, all elephantiasis patient samples were positive
for HhaI with a median of 57 copies/μl (range: 5–538;
Additional file 4A) compared to Mf-positive samples with
a median of 448 copies/μl (range 25–8252; Additional
file 4B). The IgG4 test in LE patients was positive in
only 3/9 samples (27%). Even though LE patients often
lack Mf and are negative for CFA in W. bancrofti infec-
tions, it is assumed that LE patients in endemic areas
have a constant exposure to incoming larvae (L3), which
more strongly stimulate the hosts’ immune system,
resulting in L3 killing (and thus no infection) at the
expense of tissue damage. DNA from these L3 can be
detected by the sensitive HhaI PCR.
After validating the sensitivity and specificity of the
assay, plasma samples from 229 transmigrants in South
Sulawesi and 105 life-long residents (LLR) were measured
with the HhaI PCR. All 19 Mf-positive patients were posi-
tive for HhaI and IgG4 dipstick (Additional file 1).
Defining Mf-positive (Central Sulawesi and transmi-
grants) and LE samples as having or having had an active
infection, the Mf numbers significantly correlated with
HhaI copies/μl (Figure 1, Spearman rank correlation,
r = 0.52, P < 0.001). The linear regression line from the
correlation crossed the Y-axis at 47.31 HhaI copies/μl
(SD = ±1.43) (Figure 1). The threshold of active infections
was calculated to be 53.03 HhaI copies/μl (Y-intercept
plus 4XSD) [28]. Transmigrant samples with HhaI copy
numbers below the threshold were assumed to have DNA
from L3 that were killed, but no active infection.
Using a ROC curve we were able to calculate possible
thresholds with the coordinates of the curve (Figure 2).
The variable HhaI copies/μl has at least one tie (at 53.5
HhaI copies/μl) between the sensitivity (true positive
rate, Mf positive and infected) and the 1-specificity (false
positive group, Mf-negative, uninfected/exposed). There-
fore a threshold (cutoff ) of 53.5 HhaI copies/μl was
found to best discriminate between real infections and
uninfected/exposed individuals based on PCR results.ys post infection) 2 μl and 10 μl sample DNA volume
HhaI positives
(10 μl sample volume)
Adult worm recoverya
9/9 40 (9–76)
0/9 0
Table 2 Validation of the HhaI real-time PCR using positive control patients from Central Sulawesi, Indonesia
Infection status PCR positive
(2 μl sample volume)
% PCR positive
(10 μl sample volume)
% IgG4 dipstick
positive
%
Mf positive patients (n = 30) 30/30 100 30/30 100 30/30 100
Elephantiasis patients
(Mf-positive n = 1, Mf-negative n = 8) 7/9 78 9/9 100 3/9 27
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mined with the correlation and regression line had good
discriminatory power (AUC= 0.854; P < 0.001) (Figure 2).
Using a cutoff of 53 copies/μl, 74.1% true-positive and
20% false-positive rates were calculated by ROC-curve
analysis (Figure 2, Table 3). Based on these analyses, we
set 53 HhaI copies as the cutoff to differentiate patients
with an active infection (persons infected with adult
worms) from those who only had been exposed to infect-
ive larvae.
A more detailed analysis was performed by quantifying
the HhaI gene in the transmigrant samples, sorting them
by time of residence and using the cutoff to assign infec-
tion status. A positive HhaI qPCR result could indicate
exposure to larvae (L3) (< 53 HhaI copies/μl, below cut-
off ) or infection with adult worms that may or may not
release Mf (>53 HhaI copies/μl, above cutoff ). In the
transmigrants present for less than one month all indi-
viduals had <53 HhaI copies/μl (Table 4, Figure 3). In
the 2–4 months and 3 years group, 24-25% had HhaI
levels above the cutoff, whereas IgG4 results, which de-
tect host antibodies to adult worms and Mf, were first
seen after 3 years residence (7%). After living for 4 years
in the endemic area, 69% of the transmigrants had HhaI
copy numbers above the cutoff, but only 12% were de-
tected by the IgG4 antibody test. After 4 years residence,
HhaI copy numbers in 62% of the transmigrants wereFigure 1 Determination of a threshold for infection. Mf loads
from Mf-positive and LE patients were correlated to HhaI copies/μl
(n = 58). Linear regression was performed to calculate the Y-intercept
and standard deviation of the line. The threshold was defined as:
Y-intercept (47.31) + 4XSD (1.43). Spearman Rank correlation resulted in
r = 0.52 with P < 0.001 (PASW 18.0 software package).similar to those of LLR. The IgG4 test results in 42% of
the transmigrants were similar to those of LLR after 5 years
of residence. Dividing the transmigrant population into
two groups (residence < 3 and > 3 years) there was a sig-
nificant trend for higher HhaI copy numbers in the group
living more than 3 years in the endemic area (Cochran-
Armitage test for trend P < 0.001). Additionally the num-
ber of individuals showing PCR results above the cutoff
(53 HhaI copies) was significantly increased in the 4–6 year
group (P < 0.001 Fisher’s exact test).
In summary these results indicate that in Mf-negative
individuals the PCR has a higher rate of detection than
IgG4 serology in transmigrants. After 3 or more years of
residence in the endemic area, the copy numbers for
HhaI and the respective rate of active infection in-
creases. In all groups we found samples with low HhaI
copy numbers (<53 copies). We conclude that, in most
cases, these individuals have been exposed to infective
larvae but have no active worm infection.
Discussion
Filariasis experts have requested the development of
tests that can detect infection in individuals with ultra-
low Mf densities or cryptic infections [29]. In recentFigure 2 ROC curve. HhaI copy numbers from infected individuals
(n = 58) and non-infected individuals (n = 50) were plotted to create
a ROC curve with corresponding coordinates of the curve and statistics
for the Area Under the Curve (blue line). A possible threshold is shown
in dashed lines with values (%) for Sensitivity (true positive rate) and
1-Specificity (false positive rate) (PASW 18.0 software package).
Table 3 Coordinates of ROC curve
Positive if greater
than or equal To
Sensitivity
(True positive)
1-Specificity
(False positive)
1.00 1.000 1.000
1.50 1.000 .760
2.50 1.000 .740
3.50 1.000 .720
4.50 1.000 .660
5.50 .983 .580
6.50 .983 .560
7.50 .966 .520
8.50 .948 .520
9.50 .948 .500
12.00 .948 .480
14.50 .948 .460
15.50 .948 .440
16.50 .948 .420
17.50 .948 .400
18.50 .948 .380
19.50 .948 .360
22.00 .931 .340
24.50 .897 .340
25.50 .879 .320
26.50 .879 .300
29.50 .862 .280
32.50 .845 .280
33.50 .845 .260
35.50 .828 .260
39.50 .810 .260
43.50 .810 .240
45.50 .793 .240
47.00 .776 .240
50.00 .741 .240
53.50 .741 .200
56.00 .724 .200
58.50 .707 .200
61.00 .707 .180
66.00 .707 .160
70.50 .690 .160
72.00 .690 .140
80.00 .672 .140
88.00 .655 .140
90.00 .638 .140
95.50 .638 .120
106.00 .621 .120
119.00 .603 .120
Table 3 Coordinates of ROC curve (Continued)
126.50 .586 .120
128.00 .586 .100
150.50 .569 .100
179.50 .552 .100
200.50 .517 .100
220.00 .500 .100
226.50 .483 .100
239.00 .483 .080
255.00 .466 .080
264.50 .448 .080
313.50 .431 .080
378.00 .414 .080
404.50 .397 .080
425.50 .379 .080
443.50 .362 .080
448.00 .345 .080
452.00 .328 .080
472.50 .310 .080
514.50 .293 .080
543.00 .276 .080
579.50 .259 .080
644.50 .259 .060
689.50 .241 .060
734.00 .224 .060
787.50 .207 .060
867.50 .190 .060
950.00 .172 .060
980.50 .155 .060
1021.00 .155 .040
1092.50 .138 .040
1303.50 .138 .020
1479.50 .138 .000
1487.50 .121 .000
1494.00 .103 .000
1611.00 .086 .000
2439.50 .069 .000
3173.00 .052 .000
3665.00 .034 .000
5964.00 .017 .000
7792.00 .000 .000
Bold text indicates the cut-off that is used to differentiate active infection
from exposure.
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for brugian infections, but were mainly based on Mf
positive samples. To meet the request for tests that
Table 4 Detection of B. malayi HhaI in transmigrants and life-long residents in South Sulawesi, Indonesia
Length of
residence
Analyzed
individuals
Children/
Adultsa
Mf prevalence HhaI PCR prevalence
> 53 copies (%)
HhaI PCR prevalence
< 53 copies (%)b
IgG4 BmR1
prevalence (%)
≤ 1 month 15 1/14 - c 0/15 (0) 12/15 (80) 0/15 (0)
2-4 months 33 10/23 - c 8/33 (24) 17/33 (52) 0/33 (0)
3 years 67 34/33 0d 17/67 (25) 41/67 (61) 5/67 (7)
4 years 52 19/33 0 36/52 (69) 14/52 (27) 6/52 (12)
5 - 6 years 60 28/32 5 36/60 (60) 14/60 (23) 25/60 (42)
LLR 105 71/34 14 65/105 (62) 30/105 (29) 42/105 (40)
Total 334 165/169 19
aChildren ≤ 15 years, adults 16 years + .
bAll samples < 2 HhaI copies/μl were considered PCR negative (detection limit), all samples < 53 HhaI copies/μl were considered as not infected.
cFor logistic reasons blood was collected during daytime in 2 villages, therefore Mf counts are absent.
dMf prevalence in the 3-year residents could be determined in 20 individuals only.
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due to successful MDA, we modified the HhaI Quanti-
Tect® PCR, previously developed by Rao et al. [19] by
using a novel mastermix setup that allowed us to in-
crease the sample DNA volume to 50% of the reaction
volume. We validated the new assay with a B. malayi
animal model and a unique sample set from an Indo-
nesian transmigrant population with a known history
of time spent in an endemic area. In our experiments,
the optimized qPCR assay was sensitive at detecting
Brugia DNA in pre-patent amicrofilaremic animals,
Mf-positive patients from Central Sulawesi and in a large
set of amicrofilaremic patients from South Sulawesi. These
results are novel to previous studies, as we were especially
focusing on Mf-negative samples with a pre-patent, latent
or cryptic/occult infection. These groups are often seen
in the related W. bancrofti infections for which a specific
antigen test is available.Figure 3 Stratification of B. malayi HhaI copies/μl in
transmigrants and life-long residents. Transmigrants resident
<3 years had significantly fewer HhaI copies/μl than those resident
>4 years, who had HhaI loads similar to LLR (Cochran-Armitage test
for trend P < 0.001).The 320-bp HhaI tandem repeat sequence of B. malayi
has been used as a target for B. malayi PCR assays for
many years [19,20]. Rao et al. found that detection of the
Brugia HhaI repeat was as sensitive as microscopic detec-
tion of Mf analyzing mainly Mf-positive samples from a
highly endemic area [19]. Additionally, the real-time PCR
assay showed higher sensitivity compared to conventional
PCR and TaqMan PCR assays and detected DNA of
nocturnally periodic B. malayi in day blood samples.
This represented a significant improvement over previ-
ously available diagnostic methods in brugian filariasis.
The HhaI repeat is specific for brugian filariasis and is
not detected in W. bancrofti infections, which is also
endemic in South East Asia. The PCR does not cross-
react with other common worm infections, further
underscoring the specificity of the assay as seen in our
results and by Rao et al. [19]. We were able to confirm
the sensitivity of the assay in different states of infection
using samples from B. malayi infected but pre-patent
jirds, from uninfected jirds and samples from patients
with LE who were mostly amicrofilaremic and possibly
without adult worm infection (assuming similar infec-
tion kinetics as with bancroftian LE).
The question arose whether the qPCR was able to detect
circulating worm DNA in plasma without circulating Mf,
a case that would be seen in pre-patent infections and
chronic pathology such as LE. From our results we con-
cluded that this was the case, and it is also in concordance
with other worm infections, e.g. schistosomiasis in which
a positive PCR result was seen while worms were estab-
lishing liver infection, i.e. in pre-patency [30].
LF is mainly diagnosed by direct microscopic demon-
stration of Mf in peripheral night blood of infected people.
However, this method does not detect amicrofilaremic
individuals with adult worm infection, i.e., latent or pre-
patent infections, who are still at risk of developing
pathology. For W. bancrofti infections, assessment of
antigenemia using the ICT® or TropBio® ELISA test kits is
available to detect infections in amicrofilaremic individuals
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[31]. It could be shown in bancroftian filariasis that ap-
proximately twice as many individuals are CFA + than are
microfilaremic [11]. Ultrasonography (USG), an additional
tool for W. bancrofti diagnosis, can be used to detect adult
filarial worms by their “filarial dance sign” [32]. In brugian
filariasis, accounting for 10% of the 120 million worldwide
LF infections, no antigen test is available and attempts to
reliably detect adult filariae with USG examinations have
failed [33] or did not allow reliable, frequent detection [12].
To get a more detailed view of the sensitivity of the
HhaI assay, particularly in amicrofilaremic infections, we
analyzed a large number of individuals that had moved
from a non-endemic area to a B. malayi endemic area.
In the group of individuals who were in the endemic
area less than four years, our results showed a very high
HhaI positive rate (up to 80%), whereas none of these
individuals were IgG4 positive. The high rate of detec-
tion in this group of transmigrants was unexpected. We
concluded that the positive PCR results were due to ex-
posure to infective larvae, not to active infections with
adult worms. As the HhaI copy numbers were very low in
these groups we defined a threshold which could discrim-
inate between exposed and infected individuals based on
real-time PCR results.
For monitoring Brugia infections using day samples
we used ROC-curve analysis to set the threshold associ-
ated with active infection to >53 HhaI copies/μl in a re-
action using 10 μl of plasma DNA and the QuantiTect®
Virus NR Kit. This analysis predicted a 74.1% true-positive
result for detecting an active infection in Mf-negative
people. To our knowledge, this is the first time that results
of qPCR in B. malayi infections have been used to dis-
criminate between active adult worm infections and
exposure to infective L3 larvae. The threshold found in
our results may require a trial at other endemic sites, or
a multicenter trial, to confirm the current cutoff. Com-
paring LLR to the transmigrants present in the endemic
area for 6 years, the percent of Mf-positives are 13% and
12%, respectively, showing that over time, the infections
detected in the transmigrant population are not false
alarms. It is also possible to set a higher threshold based
on the coordinates of the ROC curve. For example a
threshold set at 100 HhaI copies for active infections,
with a decreased true positive rate (62%) and respect-
ively decreased false positive rate (12%), would reflect
more or less the results of the IgG4 antibody test. If the
threshold is set at 53 HhaI copies, the likelihood to de-
tect exposed but not yet infected individuals is higher.
The results show that PCR cannot replace individual
diagnostics for the determination of infection status,
but could help mapping endemic areas which is import-
ant for monitoring mass drug administration (MDA)
programs [9,18,19].The discrepancy of PCR and IgG4 results in the first
years of living in an endemic area may be due to the PCR
sensitivity for incoming larvae, most of which will not
develop into an active infection. Edeson et al. showed in
animal experiments with B. malayi that only 13% of over
400 injected larvae develop into adult worms [34]. The
87% of the larvae that are killed would then be detected
by PCR and do not reflect active infection. The parasite
burden in the first years after transmigration is probably
not high enough to produce detectable IgG4 antibodies,
whereas PCR is able to detect parasite DNA in individuals
that are exposed to infective larvae. Notably there were in-
dividuals with high HhaI copies/μl who were IgG4 nega-
tive. Based on serology they would have been diagnosed as
Brugia negative even though it is likely they have pre-
patent or at one time had active infections. Conversely,
however, there were also 19 IgG4 positive individuals that
were diagnosed as PCR-negative, indicating previous ex-
posure to filarial worms or larvae but no current active in-
fection. Regarding the population dynamics of B. malayi
our qPCR results showed that HhaI copies/μl increase
with length of time in the area, and indicate the develop-
ment of active infections.
Introduction of the CFA test for W. bancrofti infec-
tions showed that 50% of the population in an endemic
area had a latent infection. In our study with a highly
sensitive and specific qPCR targeting the B. malayi HhaI
repeat sequence we observed a similar level of latent
infections with B. malayi infections that, importantly,
would not be detected by IgG4 serology or microscopy.
Compared to an antigen test used for W. bancrofti infec-
tion the qPCR is more expensive, but there is currently
no other method available for detecting B. malayi infec-
tions in Mf-negative persons with latent infections.
Conclusions
The modified real-time PCR for the HhaI repeat sequence,
which is highly sensitive and specific for B. malayi, may
become an effective method for monitoring B. malayi
control programs. Due to possible development of severe
LF pathology such as lymphedema, the ability to deter-
mine the status of infection, especially in amicrofilaremic
patients, as early as possible could lead to prevention of
disease progression in individuals of endemic areas.
Additionally, identifying possible recrudescence after
MDA early could help local health services intervene and
prevent wide-spread recrudescence that might otherwise
require several years of MDA to be implemented. In
the absence of an antigen test for brugian infections
the optimized B. malayi HhaI PCR can be used to
identify infected Mf-negative individuals and should
also be useful for assessing the success of MDA in the
framework of the Global Programme to Eliminate
Lymphatic Filariasis.
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